Sturm, Ruger & Company heads into its May 27 quarterly report with short sellers pulling back and a deeply skewed options market that has defined the stock's character for weeks.
The most striking feature of current positioning is the options market. Put/call ratios for RGR have been running far above any normal baseline — the 20-day average PCR of 3.75 is roughly triple what you'd see in a typical mid-cap name. The latest reading of 3.65 is almost exactly in line with that elevated average, with a z-score near zero, meaning the heavy put bias isn't a fresh development but a persistent structural feature of how options traders are using this stock. The 52-week peak hit 6.41 back on April 20, which coincided with peak short interest and maximum borrow cost — that cluster has since unwound, but the broad put-heavy stance remains.
Short positioning tells a cleaner, less alarming story. At roughly 4% of the free float, shorts are present but far from extreme. More tellingly, the trend is firmly downward — short interest has fallen about 9.3% over the past month, from a peak near 733,000 estimated shares in late April back to around 637,000 today. Borrow costs barely register at 0.51% annualised, and availability in the lending pool is ample. Nothing in the lending data suggests stress or squeeze pressure. The short score of 39.8 is mid-range and drifting slightly lower — consistent with a position that is being unwound methodically, not one that is building.
Analyst coverage of RGR is thin, and the only recent action worth noting is Lake Street's target raise from $41 to $43 in early March, maintaining a Buy — a modest move that came just after the stock's last earnings event. All other analyst data on record dates to 2020 or earlier and should not be treated as live guidance. The mean price target of $45.50 implies modest upside from the current $41.77, which is broadly consistent with a stock that has recovered 1.9% on the month after bouncing 1.9% on Tuesday alone, but still gave back 3.1% on the week. Valuation multiples are undemanding: a P/E near 15.5x and EV/EBITDA around 7.6x suggest the market is pricing RGR as a mature, cyclical consumer-goods business rather than a growth story.
The ownership structure adds one distinctive wrinkle. Beretta Holding holds nearly 10% of shares outstanding — a strategic stake that limits the effective free float and concentrates control. Below that, the register is a familiar mix of passive giants: BlackRock at 8.2%, Vanguard at 5.7%, and a handful of quant and multi-strategy funds. Millennium Management and Jane Street each appear to have built fresh positions as of the last filing period, though those reports run to year-end 2025. Insider activity in early March was routine — a cluster of award-and-partial-sell transactions at $37.11, well below current prices, with individual values in the low five figures and significance scores of 1. None of it constitutes a signal.
On the peer front, the week was mixed across comparable names. Smith & Wesson parent SWBI — the closest publicly traded firearm manufacturer — was essentially flat on the week, down just 0.3%, outperforming RGR's 3.1% decline. MCFT gained 1.6% over the same period. The divergence is modest but worth tracking — if sector tailwinds remain neutral, RGR's relative underperformance this week may reflect stock-specific caution ahead of the May 27 print.
The Q1 2026 report on May 27 is the next focal point — with options positioning structurally heavy on puts and short interest on a steady retreat, the balance of attention will rest on whether unit volume and margins can justify even the current modest multiple.
See the live data behind this article on ORTEX.
Open RGR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
